NHS Framework for the North of England, Branded Medicine

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source: Find a Tender
Type: Framework (Supply)
Duration: 2 year (est.)
Value: £169M

Sector: HEALTH
Published: 01 Mar 2022
Delivery: 01 Mar 2022 to 29 Feb 2024 (est.)
Deadline: n/a

Concepts

Location

Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points

Geochart for 2 buyers and 40 suppliers

2 buyers

NHS Commissioning Board Operating Under the Name of NHS England Runcorn

27 suppliers

Biogen Maidenhead
Merck Serono Feltham
Celltrion Healthcare Slough
Ul Global Pharma Hertfordshire
Roche Products Garden City
Bayer Reading
Merck Sharpe & Dohme London
Pfizer Kent
Accord Devon
Novo Nordisk Gatwick
Napp Pharmaceuticals Cambridge
Eli Lilly Basingstoke
Ipsen Slough
Aventis Pharma Reading
Teva Castleford
CST Pharma Walsall
Takeda London
Gilead Sciences Holborn
Thornton & Ross Huddersfield
Janssen Cilag High Wycombe
Bristol Myers Squibb Uxbridge
Glaxosmithkline London
Amgen Cambridge
Ucb Pharma Slough
Zentiva Pharma London
Gedeon Richter Westminster
Sobi Swedish Orphan Biovitrum Cambridgeshire

Description

HS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)

Lot Division

1	CM/PHR/20/5600/01 - NHS Framework for the NOFE, Branded Medicines - Tranche B CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
2	CM/PHR/20/5600/02 - NHS Framework for the NOFE, Branded Medicines-Annual Tranche CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
3	CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®)-SofE CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months.
4	CM/PHR/20/5600/04-NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 18 months.
5	CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), MaE CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Award Detail

1	Biogen (Maidenhead) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
2	Merck Serono (Feltham) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
3	Celltrion Healthcare (Slough) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
4	Ul Global Pharma (Hertfordshire) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1 Contractor is an SME.
5	Roche Products (Garden City) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
6	Bayer (Reading) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
7	Merck Sharpe & Dohme (London) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
8	Pfizer (Kent) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
9	Accord (Devon) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
10	Novo Nordisk (Gatwick) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
11	Napp Pharmaceuticals (Cambridge) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
12	Eli Lilly (Basingstoke) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
13	Ipsen (Slough) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
14	Aventis Pharma (Reading) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
15	Teva (Castleford) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
16	CST Pharma (Walsall) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1 Contractor is an SME.
17	Takeda (London) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
18	Gilead Sciences (Holborn) NHS Framework for the North of England, Branded Medicines -Tranche B Reference: cm/phr/20/5600 Num offers: 23 Value: £1
19	Thornton & Ross (Huddersfield) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
20	Janssen Cilag (High Wycombe) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
21	Celltrion Healthcare (Slough) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
22	Bristol Myers Squibb (Uxbridge) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
23	Glaxosmithkline (London) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
24	Roche Products (Garden City) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
25	Merck Sharpe & Dohme (London) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
26	Pfizer (Kent) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
27	Accord (Devon) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
28	Napp Pharmaceuticals (Cambridge) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
29	Eli Lilly (Basingstoke) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
30	Amgen (Cambridge) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
31	Aventis Pharma (Reading) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
32	Ucb Pharma (Slough) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
33	Teva (Castleford) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
34	Zentiva Pharma (London) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
35	Takeda (London) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1
36	Gedeon Richter (None) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1 Contractor is an SME.
37	Sobi Swedish Orphan Biovitrum (Cambridgeshire) NHS Framework for the NOFE, Branded Medicines-Annual Tranche Reference: cm/phr/20/5600/02 Num offers: 20 Value: £1 Contractor is an SME.
38	Aventis Pharma (Reading) NHS Framework for Insulin Aspart Biosimilar (Trurapi®)-SofE Reference: cm/phr/20/5600 Num offers: 1 Value: £1
39	Aventis Pharma (Reading) NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London Reference: cm/phr/20/5600 Num offers: 1 Value: £1
40	Aventis Pharma (Reading) NHS Framework for Insulin Aspart Biosimilar (Trurapi®), MaE Reference: cm/phr/20/5600 Num offers: 1 Value: £1

Award Criteria

PRICE

CPV Codes

33600000 - Pharmaceutical products

Indicators

Options are available.
Award on basis of price.

Reference

FTS 005550-2022